WinstonWınston
Back
SES Solar logo

SES Solar

SESI
39
Drug Manufacturers - Specialty & Generic · Healthcare
Winston Score
39
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Sep 30, 2010
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Good
Stability
Weak
Valuation
Data not available

Winston Score History

The full picture

The data provided contains significant inconsistencies — a company named "SES Solar Inc." placed in the Drug Manufacturers industry within Healthcare, with a market cap of essentially zero and a deeply negative ROIC of nearly -1,420%. These details suggest this may be a shell company, a ticker in transition, or a data error rather than an operating business.

Because reliable, verifiable information about SES Solar Inc. (SESI) as a functioning company is not available, writing a factual two-paragraph description is not possible without risking spreading inaccurate information to investors.

**What you can do:** - Double-check the ticker symbol on a primary source like SEC EDGAR (edgar.sec.gov) - Verify whether this company has filed recent 10-K or 10-Q reports - Confirm the correct industry classification with your data provider

If you can provide corrected or additional details — such as what the company actually does, its products, or a recent filing — I'm happy to write an accurate description right away.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

>+1,000% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

69.5%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$150,707 cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

SES Solar grew revenue 10678% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
22.7%
Thin — 22.7% gross margin
Profit after running costs
Operating Margin
14.3%
Healthy — 14.3% operating margin
Return on the money invested
ROCE
1.4%
Weak — 1.4% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+324.6%
Fast-growing sales (+324.6% YoY)
Profit growth
EPS YoY
-21.1%
Earnings shrinking (-21.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
143%
Turns 143% of profit into real cash
Spare cash per sale
FCF Margin
-0.1%
Burning cash (-0.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
3.07
Heavy debt load (3.07)
Covers its interest
Interest Cover
3.01x
Tight — interest eats into profit (3.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial